The Court of Justice of the European Communities rejects the Commission’s appeal against the annulment of the rejection of exemption’s application (GlaxoSmithKline)
*This article is an automatic translation of the original article, provided here for your convenience. Read the original article.
The general terms and conditions of sale applied by a drug manufacturer to its wholesalers implied, because of a differential pricing system, more onerous conditions when the products were intended for export.
Since the agreement had the object of restricting parallel trade, the cartel infringement was initially upheld
Access to this article is restricted to subscribers
Already Subscribed? Sign-in